361 related articles for article (PubMed ID: 10522720)
1. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.
Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C
Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720
[TBL] [Abstract][Full Text] [Related]
2. K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas.
Bartsch D; Bastian D; Barth P; Schudy A; Nies C; Kisker O; Wagner HJ; Rothmund M
Ann Surg; 1998 Jul; 228(1):79-86. PubMed ID: 9671070
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
4. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
Mueller J; Gansauge S; Mattfeldt T
Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
[TBL] [Abstract][Full Text] [Related]
6. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
7. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients.
Sessa F; Solcia E; Capella C; Bonato M; Scarpa A; Zamboni G; Pellegata NS; Ranzani GN; Rickaert F; Klöppel G
Virchows Arch; 1994; 425(4):357-67. PubMed ID: 7820300
[TBL] [Abstract][Full Text] [Related]
8. Mucinous Cystic Neoplasms Lined by Abundant Mucinous Epithelium Frequently Involve KRAS Mutations and Malignant Progression.
Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Aoki T; Murakami M; Mizukami H; Tanaka JI; Takimoto M
Anticancer Res; 2017 Dec; 37(12):7063-7068. PubMed ID: 29187496
[TBL] [Abstract][Full Text] [Related]
9. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD
Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas.
Z'graggen K; Rivera JA; Compton CC; Pins M; Werner J; Fernández-del Castillo C; Rattner DW; Lewandrowski KB; Rustgi AK; Warshaw AL
Ann Surg; 1997 Oct; 226(4):491-8; discussion 498-500. PubMed ID: 9351717
[TBL] [Abstract][Full Text] [Related]
11. Genomic Characterization of Low- and High-Grade Pancreatic Mucinous Cystic Neoplasms Reveals Recurrent KRAS Alterations in "High-Risk" Lesions.
Conner JR; Mariño-Enríquez A; Mino-Kenudson M; Garcia E; Pitman MB; Sholl LM; Srivastava A; Doyle LA
Pancreas; 2017; 46(5):665-671. PubMed ID: 28196015
[TBL] [Abstract][Full Text] [Related]
12. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.
Pellegata NS; Sessa F; Renault B; Bonato M; Leone BE; Solcia E; Ranzani GN
Cancer Res; 1994 Mar; 54(6):1556-60. PubMed ID: 8137263
[TBL] [Abstract][Full Text] [Related]
13. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.
Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM
Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455
[TBL] [Abstract][Full Text] [Related]
14. Incidence of P53 and K-ras alterations in ovarian mucinous and serous tumors.
Morita K; Ono Y; Fukui H; Tomita S; Ueda Y; Terano A; Fujimori T
Pathol Int; 2000 Mar; 50(3):219-23. PubMed ID: 10792785
[TBL] [Abstract][Full Text] [Related]
15. K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases.
Cuatrecasas M; Villanueva A; Matias-Guiu X; Prat J
Cancer; 1997 Apr; 79(8):1581-6. PubMed ID: 9118042
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
17. Colloid (mucinous noncystic) carcinoma of the pancreas.
Adsay NV; Pierson C; Sarkar F; Abrams J; Weaver D; Conlon KC; Brennan MF; Klimstra DS
Am J Surg Pathol; 2001 Jan; 25(1):26-42. PubMed ID: 11145249
[TBL] [Abstract][Full Text] [Related]
18. Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study.
Postlewait LM; Ethun CG; McInnis MR; Merchant N; Parikh A; Idrees K; Isom CA; Hawkins W; Fields RC; Strand M; Weber SM; Cho CS; Salem A; Martin RC; Scoggins C; Bentrem D; Kim HJ; Carr J; Ahmad S; Abbott DE; Wilson GC; Kooby DA; Maithel SK
JAMA Surg; 2017 Jan; 152(1):19-25. PubMed ID: 27760255
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
20. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
